المؤلفون: Leyland, Rebecca, Watkins, A., Mulgrew, K.A., Holoweckyj, N., Bamber, L., Tigue, N.J., Offer, E., Andrews, J., Yan, L., Mullins, S., Oberst, M.D., Ulrichsen, J.C., Leinster, D.A., McGlinchey, K., Young, L., Morrow, M., Hammond, S.A., Mallinder, P., Herath, A., Ching Leow, C., Wilkinson, R.W., Stewart, R.

Relation: http://shura.shu.ac.uk/27547/; LEYLAND, Rebecca, WATKINS, A., MULGREW, K.A., HOLOWECKYJ, N., BAMBER, L., TIGUE, N.J., OFFER, E., ANDREWS, J., YAN, L., MULLINS, S., OBERST, M.D., ULRICHSEN, J.C., LEINSTER, D.A., MCGLINCHEY, K., YOUNG, L., MORROW, M., HAMMOND, S.A., MALLINDER, P., HERATH, A., CHING LEOW, C., WILKINSON, R.W. and STEWART, R. (2017). A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy that Is Further Enhanced in Combination with an OX40 Agonist. Clinical Cancer Research, 23 (13), 3416-3427.

الاتاحة: https://doi.org/10.1158/1078-0432.CCR-16-2000